Details
Stereochemistry | ACHIRAL |
Molecular Formula | C21H38O4 |
Molecular Weight | 354.524 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 2 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCC\C=C/C\C=C/CCCCCCCC(=O)OC(CO)CO
InChI
InChIKey=IEPGNWMPIFDNSD-HZJYTTRNSA-N
InChI=1S/C21H38O4/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-21(24)25-20(18-22)19-23/h6-7,9-10,20,22-23H,2-5,8,11-19H2,1H3/b7-6-,10-9-
Molecular Formula | C21H38O4 |
Molecular Weight | 354.524 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 2 |
Optical Activity | NONE |
Glyceryl 2-linoleate is a fatty acid derivative. It inhibits monoacylglycerol lipase and fatty acid amide hydrolase activity. Glyceryl 2-linoleate enhanced a 2-Arachidonoyl-glycerol inhibition of tumor necrosis factor alpha production in murine macrophages when applied with 2-Arachidonoyl-glycerol. Initially, it was found that Glyceryl 2-linoleate potentiated the apparent binding of 2-Arachidonoyl-glycerol to cannabinoid receptors CB1 and CB2. However, later research revealed that in no case do the lipid Glyceryl 2-linoleate acts as entourage compounds for 2-Arachidonoyl-glycerol. Increase in Glyceryl 2-linoleate plasma concentrations was observed in cocaine subjects diagnosed with psychiatric comorbidity.
CNS Activity
Sources: https://www.ncbi.nlm.nih.gov/pubmed/9721036 | https://www.ncbi.nlm.nih.gov/pubmed/27117667
Curator's Comment: Known to be CNS penetrant in mouse. Human data not available.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL3321 Sources: https://www.ncbi.nlm.nih.gov/pubmed/15492019 |
22.0 µM [IC50] | ||
Target ID: CHEMBL3229 Sources: https://www.ncbi.nlm.nih.gov/pubmed/15492019 |
12.0 µM [IC50] | ||
Target ID: 2-Arachidonoyl-glycerol |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Diagnostic | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity. | 1998 Jul 17 |
|
2-Arachidonylglycerol, an endogenous cannabinoid, inhibits tumor necrosis factor-alpha production in murine macrophages, and in mice. | 2000 Oct 6 |
|
Critical role of the endogenous cannabinoid system in mouse pup suckling and growth. | 2001 May 11 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/9721036
Mice: 10 mg/kg
Route of Administration:
Intraperitoneal
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/9721036
In RBL-2H3 cells was found that without the addition of GLYCERYL 2-LINOLEATE, 2-Arachidonoyl-glycerol (2-Ara-Gl) disappeared from the culture media in a temperature-dependent fashion with a half life at 37C of 6 min. 100 uM of GLYCERYL 2-LINOLEATE prevented this loss of 2-Ara-Gl from the medium. An eight-fold increase of 2-Ara-Gl levels was observed after 30 min incubation.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 22:25:25 GMT 2023
by
admin
on
Fri Dec 15 22:25:25 GMT 2023
|
Record UNII |
7OVH75512R
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C114955
Created by
admin on Fri Dec 15 22:25:25 GMT 2023 , Edited by admin on Fri Dec 15 22:25:25 GMT 2023
|
PRIMARY | |||
|
5365676
Created by
admin on Fri Dec 15 22:25:25 GMT 2023 , Edited by admin on Fri Dec 15 22:25:25 GMT 2023
|
PRIMARY | |||
|
75457
Created by
admin on Fri Dec 15 22:25:25 GMT 2023 , Edited by admin on Fri Dec 15 22:25:25 GMT 2023
|
PRIMARY | |||
|
7OVH75512R
Created by
admin on Fri Dec 15 22:25:25 GMT 2023 , Edited by admin on Fri Dec 15 22:25:25 GMT 2023
|
PRIMARY | |||
|
3443-82-1
Created by
admin on Fri Dec 15 22:25:25 GMT 2023 , Edited by admin on Fri Dec 15 22:25:25 GMT 2023
|
PRIMARY | |||
|
DTXSID301016998
Created by
admin on Fri Dec 15 22:25:25 GMT 2023 , Edited by admin on Fri Dec 15 22:25:25 GMT 2023
|
PRIMARY |